RENEGADE THERAPEUTICS
Heat Biologics, Inc.
Mark For: RENEGADE THERAPEUTICS® trademark registration is intended to cover the category of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90243059 |
| Registration Number | 1592439 |
| Mark Literal Elements | RENEGADE THERAPEUTICS |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED 2021-10-01 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Rachelle A. Dubow, Esq. |
| Attorney Docket Number | 114358-0002 |
Timeline
| 2020-10-08 | Application Filed |
| 2020-10-12 | Location: NEW APPLICATION PROCESSING |
| 2020-10-12 | Status: Live/Pending |
| 2020-10-12 | Transaction Date |
| 2021-10-01 | Location: TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED |
| 2021-10-01 | Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi |
Trademark Parties (Applicants & Owners)
| Party: |  Heat Biologics, Inc. |
| Address | 801 Capitola Drive, Bay 12 Durham, NORTH CAROLINA UNITED STATES 27713 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | 2020-10-08 | |
| Drawing | 2020-10-08 | |
| XSearch Search Summary | 2021-03-11 | |
| Offc Action Outgoing | 2021-03-17 | |
| Notice of Abandonment | 2021-10-01 |
Attorney of Record
Good, Services, and Codes
(ABANDONED)
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical products for the treatment or prevention of cancer and immune-related diseases(ABANDONED)
IC 042. US 100 101. G & S: Research and development of pharmaceutical products
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical products for the treatment or prevention of cancer and immune-related diseases |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | 2021-10-01 | |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2021-10-01 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-03-17 | 6325 |
| NON-FINAL ACTION WRITTEN | 2021-03-17 | 86708 |
| NON-FINAL ACTION E-MAILED | 2021-03-17 | 6325 |
| ASSIGNED TO EXAMINER | 2021-03-08 | 86708 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-11-23 | |
| NEW APPLICATION ENTERED IN TRAM | 2020-10-12 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 